HPGD anticorps (AA 55-160)
-
- Antigène Voir toutes HPGD Anticorps
- HPGD (Hydroxyprostaglandin Dehydrogenase 15-(NAD) (HPGD))
-
Épitope
- AA 55-160
-
Reactivité
- Humain, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp HPGD est non-conjugé
-
Application
- ELISA, Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Réactivité croisée
- Humain, Rat
- Homologie
- Mouse,Cow,Pig,Horse,Rabbit
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic peptide derived from human Prostaglandin dehydrogenase 1
- Isotype
- IgG
- Top Product
- Discover our top product HPGD Anticorps primaire
-
-
- Indications d'application
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Date de péremption
- 12 months
-
-
15-PGDH expression as a predictive factor response to neoadjuvant chemotherapy in advanced gastric cancer." dans: International journal of clinical and experimental pathology, Vol. 8, Issue 6, pp. 6910-8, (2015) (PubMed).
: "15-PGDH/15-KETE plays a role in hypoxia-induced pulmonary vascular remodeling through ERK1/2-dependent PAR-2 pathway." dans: Cellular signalling, Vol. 26, Issue 7, pp. 1476-1488, (2014) (PubMed).
: "
-
15-PGDH expression as a predictive factor response to neoadjuvant chemotherapy in advanced gastric cancer." dans: International journal of clinical and experimental pathology, Vol. 8, Issue 6, pp. 6910-8, (2015) (PubMed).
-
- Antigène
- HPGD (Hydroxyprostaglandin Dehydrogenase 15-(NAD) (HPGD))
- Autre désignation
- Prostaglandin Dehydrogenase 1 (HPGD Produits)
- Synonymes
- anticorps CBR, anticorps SDR21C1, anticorps hCBR1, anticorps 15-PGDH, anticorps PGDH, anticorps PGDH1, anticorps PHOAR1, anticorps SDR36C1, anticorps MGC80546, anticorps MGC79454, anticorps AV026552, anticorps carbonyl reductase 1, anticorps 15-hydroxyprostaglandin dehydrogenase, anticorps hydroxyprostaglandin dehydrogenase 15-(NAD), anticorps 15-hydroxyprostaglandin dehydrogenase L homeolog, anticorps hydroxyprostaglandin dehydrogenase 15 (NAD), anticorps CBR1, anticorps HPGD, anticorps hpgd.L, anticorps hpgd, anticorps pgdh, anticorps Hpgd, anticorps PTRG_03214, anticorps VDBG_09957
- Sujet
-
Synonyms: PGDH, PGDH1, PHOAR1, 15-PGDH, SDR36C1, 15-hydroxyprostaglandin dehydrogenase [NAD(+)], Prostaglandin dehydrogenase 1, HPGD
Background: Prostaglandin inactivation. Contributes to the regulation of events that are under the control of prostaglandin levels. Catalyzes the NAD-dependent dehydrogenation of lipoxin A4 to form 15-oxo-lipoxin A4. Inhibits in vivo proliferation of colon cancer cells.
- ID gène
- 3248
- UniProt
- P15428
-